Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380-1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trial
Gilead Sciences
Paul E Sax; Anton Pozniak; M Luisa Montes; Ellen Koenig; Edwin DeJesus; Hans-Jürgen Stellbrink; Andrea Antinori; Kimberly Workowski; Jihad Slim; Jacques Reynes; Will Garner; Joseph Custodio; Kirsten White; Devi SenGupta; Andrew Cheng; Erin Quirk